CA11-19
Dead / Cancelled — Cancelled — Section 8 (as of 04 Feb 2022)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86165401
- Registration number
- 4782763
- Mark type
- Stylized text
- Filed
- 14 Jan 2014
- Published for opposition
- 02 Sept 2014
- Registered
- 28 Jul 2015
- Attorney of record
- Danielle I. Mattessich
Goods and services
- Class 005 — Pharmaceuticals: medical diagnostic reagents, namely, reagents in the form of a glycoprotein antigen for use in the detection of cancer and an immunoblobulin reagent in the form of an antibody with specificity to that antigen for use in the detection of cancer
Owner
- EDP Biotech Corporation, Knoxville, TN, US
- EDP Biotech Corporation, Knoxville, TN, US
- EDP Biotech Corporation, Knoxville, TN, US
Prosecution history
- 04 Feb 2022 — CANCELLED SEC. 8 (6-YR)
- 28 Jul 2020 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 28 Jul 2015 — REGISTERED-PRINCIPAL REGISTER
- 24 Jun 2015 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Jun 2015 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Jun 2015 — STATEMENT OF USE PROCESSING COMPLETE
- 24 Apr 2015 — USE AMENDMENT FILED
- 26 May 2015 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Apr 2015 — TEAS STATEMENT OF USE RECEIVED
- 22 Apr 2015 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 22 Apr 2015 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Oct 2014 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Sept 2014 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Sept 2014 — PUBLISHED FOR OPPOSITION
- 13 Aug 2014 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED